U.S. markets closed

Altimmune, Inc. (ALT)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
12.94-0.24 (-1.82%)
At close: 4:00PM EST
Get access to 40+ years of historical data with Yahoo Finance Premium.Learn more
Currency in USD

Valuation Measures

Premium required to access annual data
Annual
Quarterly
Premium required to access monthly data
Monthly
Subscribe to Premium to download historical data
 
As of Date: 3/1/2021
Current
12/31/20209/30/20206/30/20203/31/202012/31/2019
Market Cap (intraday) 5
592.18M418.97M436.56M284.39M49.30M28.94M
Enterprise Value 3
378.08M214.08M358.59M253.15M13.81M-8.35M
Trailing P/E
1.82N/AN/AN/AN/A1.95
Forward P/E 1
N/AN/AN/AN/AN/AN/A
PEG Ratio (5 yr expected) 1
N/AN/AN/AN/AN/AN/A
Price/Sales (ttm)
50.2035.5349.9430.767.262.76
Price/Book (mrq)
2.962.105.496.791.080.59
Enterprise Value/Revenue 3
46.1992.57122.05350.816.24-14.50
Enterprise Value/EBITDA 6
-6.98-20.10-19.73-13.86-1.962.07

Trading Information

Stock Price History

Beta (5Y Monthly) 1.37
52-Week Change 3309.49%
S&P500 52-Week Change 339.88%
52 Week High 335.10
52 Week Low 32.50
50-Day Moving Average 317.53
200-Day Moving Average 314.10

Share Statistics

Avg Vol (3 month) 31.74M
Avg Vol (10 day) 31.65M
Shares Outstanding 537.15M
Float 29.2M
% Held by Insiders 16.51%
% Held by Institutions 167.29%
Shares Short (Feb 11, 2021) 42.52M
Short Ratio (Feb 11, 2021) 41.35
Short % of Float (Feb 11, 2021) 47.82%
Short % of Shares Outstanding (Feb 11, 2021) 46.79%
Shares Short (prior month Jan 14, 2021) 42.6M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3Sep 13, 2018
Ex-Dividend Date 4Jan 19, 2017
Last Split Factor 21:30
Last Split Date 3Sep 13, 2018

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2020
Most Recent Quarter (mrq)Dec 30, 2020

Profitability

Profit Margin 0.00%
Operating Margin (ttm)-470.78%

Management Effectiveness

Return on Assets (ttm)-16.10%
Return on Equity (ttm)-36.14%

Income Statement

Revenue (ttm)8.19M
Revenue Per Share (ttm)0.32
Quarterly Revenue Growth (yoy)301.70%
Gross Profit (ttm)-25.32M
EBITDA -38.24M
Net Income Avi to Common (ttm)-49.04M
Diluted EPS (ttm)-1.91
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)215.92M
Total Cash Per Share (mrq)5.84
Total Debt (mrq)1.82M
Total Debt/Equity (mrq)0.81
Current Ratio (mrq)19.16
Book Value Per Share (mrq)6.11

Cash Flow Statement

Operating Cash Flow (ttm)-34.44M
Levered Free Cash Flow (ttm)-25.74M